Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.
about
Targeting Selectins and Their Ligands in CancerDownregulation of P-selectin glycoprotein ligand-1 as a potential anti-inflammatory mechanism.E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.Targeting P-selectin glycoprotein ligand-1/P-selectin interactions as a novel therapy for metabolic syndrome.Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic targetCan biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
P2860
Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@en
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@nl
type
label
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@en
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@nl
prefLabel
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@en
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@nl
P2093
P2860
P356
P1476
Inhibition of P-Selectin and P ...... e Myeloma Cells to Bortezomib.
@en
P2093
Abdel Kareem Azab
Barbara Muz
Pilar de la Puente
Richard Alvarez
Scott Rollins
Ziad Kawar
P2860
P304
P356
10.1155/2015/417586
P407
P577
2015-10-11T00:00:00Z